Moderna and Pfizer are the first companies to enter Phase 3 clinical testing on a COVID-19 vaccine in the U.S. Each company plans to blind test 30,000 volunteers in hopes of having results and possibly effective vaccines by the end of the year. Meg Oliver reports. Source


And get notified everytime we publish a new Important announcements. We will not email you often, unless there are important things that need to get in touch with you, such as added new tools or new domain names.